Medico Remedies Limited (NSE:MEDICO)

Market Cap	4.08B
Revenue (ttm)	1.72B
Net Income (ttm)	113.47M
Shares Out	n/a
EPS (ttm)	1.36
PE Ratio	35.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,996,508
Average Volume	219,009
Open	49.49
Previous Close	49.31
Day's Range	48.29 - 54.24
52-Week Range	37.18 - 79.83
Beta	0.23
RSI	50.82
Earnings Date	Feb 14, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In 2024, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.